P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,721.00
41.25 (0.73%)
BSENSE

Dec 17

BSE+NSE Vol: 2.46 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
942.20
-278.54
-29.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
942.20
-278.54
-29.56%
Raw Material Cost
137.67
137.80
-0.13
-0.09%
Purchase of Finished goods
34.95
119.70
-84.75
-70.80%
(Increase) / Decrease In Stocks
-10.23
191.70
-201.93
-105.34%
Employee Cost
109.89
98.70
11.19
11.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
127.50
53.27
41.78%
Total Expenditure (Excl Depreciation)
453.05
675.40
-222.35
-32.92%
Operating Profit (PBDIT) excl Other Income
210.61
266.80
-56.19
-21.06%
Other Income
8.98
12.00
-3.02
-25.17%
Operating Profit (PBDIT)
219.59
278.80
-59.21
-21.24%
Interest
0.24
0.70
-0.46
-65.71%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
278.10
-58.75
-21.13%
Depreciation
11.52
18.70
-7.18
-38.40%
Profit Before Tax
207.83
259.40
-51.57
-19.88%
Tax
53.11
70.40
-17.29
-24.56%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
189.00
-34.28
-18.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
189.00
-34.28
-18.14%
Equity Capital
16.60
23.00
-6.40
-27.83%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
82.17
11.03
13.42%
Diluted Earnings per share
93.21
82.07
11.14
13.57%
Operating Profit Margin (Excl OI)
31.73%
28.32%
0.00
3.41%
Gross Profit Margin
33.05%
29.52%
0.00
3.53%
PAT Margin
23.31%
20.06%
0.00
3.25%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024